Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Vir Biotechnology, Inc.
< Previous
1
2
Next >
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
November 02, 2023
From
Vir Biotechnology, Inc.
Via
Business Wire
Tickers
VIR
Vir Biotechnology Appoints Jennifer Towne, Ph.D., as Executive Vice President and Chief Scientific Officer
October 30, 2023
From
Vir Biotechnology, Inc.
Via
Business Wire
Tickers
VIR
Vir Biotechnology to Participate in the H.C. Wainwright 4th Annual Hepatitis B Virus (HBV) Conference
October 12, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Tickers
VIR
Vir Biotechnology Announces Multiple Abstracts Highlighting New Chronic Hepatitis B and Hepatitis Delta Data Accepted for Presentation at AASLD’s The Liver Meeting® 2023
October 11, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Tickers
VIR
Vir Biotechnology to Provide Business Update and Report Third Quarter 2023 Financial Results on November 2, 2023
October 05, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Tickers
VIR
Vir Biotechnology Awarded BARDA Funding to Support Development of Antibody Platform Technologies for Global Infectious Disease Threats
October 03, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Tickers
VIR
Vir Biotechnology Announces First Participant Dosed in New Phase 1 Trial Evaluating VIR-1388, an Investigational T Cell Vaccine for the Prevention of HIV
September 20, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Tickers
VIR
Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences
August 29, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Tickers
VIR
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2023 Financial Results
August 03, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Tickers
VIR
Vir Biotechnology to Provide Business Update and Report Second Quarter 2023 Financial Results on August 3, 2023
July 26, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Tickers
VIR
Vir Biotechnology Announces Topline Data from Phase 2 PENINSULA Trial Evaluating VIR-2482 for the Prevention of Seasonal Influenza A Illness
July 20, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Tickers
VIR
Vir Biotechnology Appoints Sasha Damouni Ellis as Executive Vice President and Chief Corporate Affairs Officer
June 29, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Tickers
VIR
Vir Biotechnology Presents New Data Evaluating the Potential for VIR-2218 and VIR-3434 as Therapies for Chronic Hepatitis B and Hepatitis D
June 24, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Tickers
VIR
Vir Biotechnology Announces Multiple Abstracts Highlighting New Hepatitis B and D Data Accepted for Presentation at EASL™ Congress 2023
June 07, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Tickers
VIR
Vir Biotechnology to Participate in the 44th Annual Goldman Sachs Global Healthcare Conference
June 05, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Tickers
VIR
Vir Biotechnology to Host a Virtual-Only 2023 Annual Meeting of Stockholders
May 17, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Tickers
VIR
Vir Biotechnology Appoints Jeff Calcagno, M.D., as Executive Vice President and Chief Business Officer
May 15, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Tickers
VIR
Vir Biotechnology Announces First Patient Dosed in New Phase 2 Chronic Hepatitis B Virus Trial Evaluating Combinations of VIR-2218, VIR-3434, PEG-IFNα and an NRTI
May 11, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Tickers
VIR
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2023 Financial Results
May 04, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Tickers
VIR
Vir Biotechnology to Participate in the BofA Securities 2023 Health Care Conference
May 03, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Tickers
VIR
Vir Biotechnology Receives Expanded Support to Develop Its Novel T Cell Vaccine Platform with New $10 Million Grant for HIV Prevention
May 02, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Tickers
VIR
Vir Biotechnology to Participate in the 22nd Annual Needham Virtual Healthcare Conference
April 11, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Tickers
VIR
Vir Biotechnology to Participate in the Barclays Global Healthcare Conference
March 08, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Tickers
VIR
Vir Biotechnology to Participate in the Cowen 43rd Annual Health Care Conference
February 28, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Tickers
VIR
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
February 23, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Tickers
VIR
Vir Biotechnology Announces Positive Final Draft Guidance on Sotrovimab from the UK’s National Institute for Health and Care Excellence (NICE)
February 22, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Tickers
VIR
Vir Biotechnology to Provide Corporate Update and Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
February 16, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Tickers
VIR
Vir Biotechnology Appoints Sung Lee as Chief Financial Officer
February 16, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Tickers
VIR
Vir Biotechnology Announces Amended Collaboration Agreement with GSK
February 13, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Tickers
VIR
Vir Biotechnology Announces Retirement of CEO George Scangos, Ph.D.; Appoints Marianne De Backer, MSc, Ph.D., MBA, as Successor
January 25, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Tickers
VIR
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.